Vertex Pharmaceuticals has presented new Phase 3 data showing positive [...]

FDA has granted orphan drug designation to Tris Pharma’s investigational [...]

Dicot Pharma has secured approximately SEK 231M (€21M) in gross [...]

CONNECTA Therapeutics has started a Phase 2a clinical trial of [...]

The National Institute for Health and Care Excellence (NICE) has [...]

Verdiva Bio has reported new preclinical data for two obesity [...]

NICE has issued draft final guidance recommending Nucala as an [...]

Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

Mestag Therapeutics has dosed the first patient in its Phase [...]

AstraZeneca’s Imfinzi (durvalumab) has been recommended by NICE for use [...]